Bioorganometallic Chemistry: Applications in Drug Discovery, Biocatalysis, and Imaging

First defined in 1985, the field of bioorganometallic chemistry studies the role of metal ions or complexes in natural biological processes a well as the practicability of these results for the development of novel drugs, biosensors, radiopharmaceuticals, and artificial enzymes. This important field has continuously expanded over the past 25 years, and the first bioorganometallics have already been applied, including platin compounds for cancer chemotherapy and technetium compounds as nuclear medicine imaging agents.
This up-to-date reference reflects the significant advances and key breakthroughs made over the last decade. The result is an overview of recent developments and future trends in the field, focusing on such applications as potentially active organometallic drugs for fighting currently incurable diseases, as well as in such areas as catalysis, energy, analytical chemistry, and imaging.
Here, the renowned editor, who is responsible for coining the term "bioorganometallics", and his international team of experts have put together a valuable resource for researchers in organometallic, inorganic, medicinal, and biochemistry.